Healthleap, a startup applying AI to hospital patient records, has raised $38 million in combined seed and Series A funding, according to TechCrunch. The round consists of an $8 million seed co-led by Sequoia Capital and First Round Capital and a $30 million Series A led by Hummingbird Ventures; valuation was not disclosed. The company was founded in South Africa in 2022 by siblings Jemima and Josiah Meyer. It began as a clinical nutrition tool Jemima built for dietitians, then pivoted to a general-purpose platform for identifying hospital patients at risk of conditions that are often not diagnosed early enough, such as malnutrition and delirium.

Healthleap plugs into a hospital’s electronic health record system. CEO Josiah Meyer explained that a patient’s chart contains structured data—labs, weights, and vital signs—but the most telling signs sit in clinicians’ written notes: poor appetite, recent weight loss, muscle loss, trouble swallowing. The company’s approach extracts affirmative or negated mentions of these clinical concepts in a scalable way. Each night, the platform analyzes every adult inpatient’s record, including lab results, vital signs, weights, medications, diet orders, diagnoses, and clinicians’ notes. Each morning, it writes a risk score into the care team’s existing workflow and provides a dashboard with additional information about patient trends. The software does not diagnose; it only flags patients who may need a closer look.

Healthleap has grown from three hospital partners to more than 50 over the past year. Its customers include Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist, and Emory Healthcare. The platform currently screens patients for malnutrition and delirium. Programs for aspiration pneumonia, pressure ulcers, and congestive heart failure readmission risk are built and undergoing further clinical validation. Revenue has grown more than 10x over the same period, though no specific figures were provided.

The startup sells three-year contracts priced according to a hospital’s licensed bed count, with an outcome-based pricing component. Josiah said the measurable ROI is validated by the hospital finance team and attributed to Healthleap. Contractually, the company commits to delivering multiples of the contract price. He stated that to date every customer has seen a 5x hard ROI or more, and in some cases over 20x annual total ROI. At the Hospital of the University of Pennsylvania, the malnutrition program produced $23.8 million in annualized financial impact: $6.3 million from additional reimbursement and $17.5 million from shorter hospital stays.

Malnutrition is a common but frequently undiagnosed condition: research cited in the article suggests 20% to 50% of hospital inpatients are malnourished, and it has been linked to longer stays, impaired wound healing, infections, and higher morbidity and mortality. Healthleap plans to spend the new funding on engineering, product, sales, and customer success as it adds support for more conditions. Meyer said the company ultimately wants to cover more than 40 major health conditions and expand into outpatient and home care.